Dianthus Therapeutics | MGTA - Рыночная капитализация





Рыночная капитализация Изменить Дата
Akebia Therapeutics USD 502M 75M 2025-03
Alaunos Therapeutics USD 5M 2M 2025-09
Avita Medical AUD 105.47M 35.32M 2025-12
Cspc Pharmaceutical CNY 107.03B 26.09B 2025-09
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.57B 967M 2025-09
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Knight Therapeutics CAD 624.22M 38.25M 2026-03
Laboratorios Farma EUR 4.16B 904.2M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 38.41M 24.12M 2026-03
Neuren Pharmaceuticals AUD 1.71B 645.78M 2026-03
Organigram Holdings CAD 378.8M 132.2M 2025-09
Organon & Co USD 1.86B 916.43M 2025-12
Ovoca Bio EUR 7.54M 4.28M 2022-06
Pharma Mar EUR 1.41B 63.87M 2026-03
Qiagen NV USD 9.9B 207.4M 2025-12
Revvity USD 10.97B 1.21B 2025-12
Sartorius EUR 16.41B 2.95B 2025-12
Sino Biopharmaceutical CNY 114.44B 24.38B 2026-03
Tectonic Therapeutic USD 294M 77M 2025-09
Viatris USD 14.34B 2.8B 2025-12
Xeris Pharmaceuticals USD 1.32B 562M 2025-09
Zealand Pharma A/S 33.35B 0 2026-02
Zz Pientze Pharmaceu CNY 118.73B 1.94B 2025-09